CLOV vs MOH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

CLOV

48.9
AI Score
VS
CLOV Wins

MOH

48.0
AI Score

Investment Advisor Scores

CLOV

49score
Recommendation
HOLD

MOH

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CLOV MOH Winner
Forward P/E 81.9672 37.8788 MOH
PEG Ratio 0 1.7814 Tie
Revenue Growth 62.0% -5.7% CLOV
Earnings Growth 0.0% -75.3% CLOV
Tradestie Score 48.9/100 48.0/100 CLOV
Profit Margin -2.6% -0.0% MOH
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CLOV 1M: -18.9% · 3M: +57.4% MOH 1M: -14.6% · 3M: +1.9%

Current Technical Phase

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.0 · Price: $4.27

MOH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 36.5 · Price: $196.40

Fundamentals Snapshot

Metric CLOV MOH
Market Cap
Forward P/E 41.7 22.9
Trailing P/E 1216.9
Revenue (TTM)
Revenue Growth 0.6% -0.1%
Gross Margin 0.2% 0.1%
Operating Margin 0.0% 0.0%
EPS -0.12 0.16
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.